Determining if an EAC is at risk and key actions to mitigate trial impact.
Shaena Kauffman
Advertisement
Executive Director, Operations EAC, WCG
Articles by Shaena Kauffman
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Executive Director, Operations EAC, WCG
Determining if an EAC is at risk and key actions to mitigate trial impact.
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
